ACDM News Item

Recent update from the regulatory landscape in clinical data management

Date: September 24, 2026

On 22 September, MHRA published a new set of inspection dossier documents specifically for computerized systems in support of clinical trials.

You can download the new templates on the MHRA GCP hub: https://www.gov.uk/guidance/clinical-trials-for-medicines-good-clinical-practice-inspections

Scroll down to the Pre-inspection documentation tab to find the:

GCP inspection dossier template – Computerised Systems
GCP inspection dossier clinical trial spreadsheet – Computerised Systems
GGP inspection dossier checklist – Computerised Systems.

MHRA last updated the dossier documents in Dec 2025 to include a new section 13 on Artificial Intelligence and Machine Learning (AI/ML). The new Computerized Systems documents continue the focus on managing and documenting usage of AI/ML and traditional computerized systems.

An initial review of the new documents underscores the MHRA emphasis on risk management throughout the entire software development lifecycle including validation status and change control.

For example in the inspection dossier spreadsheet, the tab S1 Item 4- clinical trials includes questions such as:

Number of substantial protocol amendments/modifications
Number of change controls
How many of these change controls related to a protocol amendment/modification

The ACDM DMEG for Regulatory considerations recommends that data managers review the new documents to ensure that their validation and documentation efforts will support MHRA inspections.

Explore More News

Recent update from the regulatory landscape in clinical data management

On 22 September, MHRA published a new set of inspection dossier documents specifically for . . .

Regulatory Considerations DMEG Update – August 2026

Please read the following update from the Regulatory Considerations DMEG: July and . . .

Get to know ACDM Board Member: Santosh Karthikeyan Viswanathan

We caught up with one of ACDM’s new Board Members, Santosh Karthikeyan Viswanathan, to . . .

Guidance on Decentralized Clinical Trials to be Reviewed by the ACDM RC DMEG

Health Canada (HC) continues to publish new guidelines to support their modernization of . . .

Regulatory Considerations DMEG to Review Health Canada’s Draft Guidance

Thank you to the Regulatory Considerations DMEG for sharing this update. Health Canada . . .

Recent update from the regulatory landscape in clinical data management

Thank you to the Regulatory Considerations DMEG for sharing this update. On July 15 the . . .

Regulatory Considerations DMEG Update – June 2026

Please read the following update from the Regulatory Considerations DMEG: Regulators have . . .

FDA Announces New Initiative for Real-Time Clinical Trials

The U.S. Food and Drug Administration (FDA) has announced a new initiative to support the . . .

Get to know ACDM Board Member Jennifer Duff

We caught up with one of ACDM’s new Board Members, Jennifer Duff, to learn more about her. . . .

Recent News in Regulatory Landscape

The ACDM Regulatory Considerations DMEG have kindly put together a short news piece . . .

Real-Time Clinical Data Flow: Why the FDA’s New Pilot Validates the Data Flow Modernization Agenda

Tamer Chowdhury, on behalf of ACDM Technology DMEG. On April 28, FDA Commissioner Dr. . . .

Bridging the Behaviour Gap: The Human Skills Redefining Clinical Data Management (ACDM26 Workshop Recap)

This article has been written by Gail Kniveton, who delivered the workshop “Bridging the . . .